申请人:Barta Nancy S.
公开号:US20090124695A1
公开(公告)日:2009-05-14
A prostaglandin analog with selectivity to EP receptors and demonstrating EP agonist activity that may be used to expand hematopoietic stem cell populations or to treat or prevent influenza, bone fracture, bone disease, glaucoma, ocular hypertension, dysmenorrhoea, pre-term labor, immune disorders, osteoporosis, asthma, allergy, male sexual dysfunction, female sexual dysfunction, periodontal disease, gastric ulcer, renal disease, or other EP receptor-mediated conditions.
一种选择性作用于EP受体的前列腺素类似物,表现出EP激动剂活性,可用于扩大造血干细胞群体或用于治疗或预防流感、骨折、骨病、青光眼、眼压升高、痛经、早产、免疫紊乱、骨质疏松症、哮喘、过敏、男性性功能障碍、女性性功能障碍、牙周病、胃溃疡、肾脏疾病或其他EP受体介导的疾病。